https://medicaex.com/businesswire/histowiz-appoints-linh-hoang-as-ceo-and-board-member/ 2022-10-26T13:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/HistoWiz_Website_Logo-7X6DLO.jpeg https://medicaex.com/businesswire/ligand-announces-that-janssen-has-received-approval-from-u-s-fda-for-tecvayli-teclistamab-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma/ 2022-10-26T13:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/10/Ligand-Logo-Registered5-ZIW3nJ.jpeg https://medicaex.com/businesswire/amra-medical-at-aasld-2022-premier-mri-technology-and-informatics-for-the-full-continuum-of-liver-disease-3/ 2022-10-26T13:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/10/AASLD_Banner_Liver-gldGLy.jpeg https://medicaex.com/businesswire/cue-health-to-announce-third-quarter-2022-financial-results/ 2022-10-26T13:00:35+00:00 https://medicaex.com/businesswire/surmodics-announces-transcend-trial-24-month-data-to-be-presented-at-viva-2022/ 2022-10-26T13:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Color-logo-mumihT.jpeg https://medicaex.com/businesswire/abiomed-creates-patient-assistance-program-to-address-disparities-in-healthcare/ 2022-10-26T13:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Figure_1-ToSuYC.jpeg https://medicaex.com/businesswire/radiopharm-theranostics-signs-agreement-with-northstar-medical-radioisotopes-for-the-supply-of-non-carrier-added-n-c-a-actinium-225-2/ 2022-10-26T13:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/NorthStar_Medical_Radioiostopes_LLC_logo-4cgXgB.jpeg https://medicaex.com/businesswire/amra-medical-at-aasld-2022-premier-mri-technology-and-informatics-for-the-full-continuum-of-liver-disease-2/ 2022-10-26T13:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/10/AASLD_Banner_Liver-Ka5n66.jpeg https://medicaex.com/businesswire/amra-medical-at-aasld-2022-premier-mri-technology-and-informatics-for-the-full-continuum-of-liver-disease/ 2022-10-26T13:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/AASLD_Banner_Liver-SDxs46.jpeg https://medicaex.com/businesswire/medavail-announces-technology-partnership-with-progressive-care-inc-2/ 2022-10-26T13:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/MedAvail_logo_1147x445-9wuDMI.jpeg https://medicaex.com/businesswire/medavail-announces-technology-partnership-with-progressive-care-inc/ 2022-10-26T13:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/MedAvail_logo_1147x445-FbKsJP.jpeg https://medicaex.com/businesswire/medable-enhances-patient-experience-in-oncology-clinical-trials-to-increase-access-enrollment-retention-3/ 2022-10-26T12:00:57+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo_Full_Color_2x-aCL3Y6.jpeg https://medicaex.com/businesswire/massive-bio-onboards-over-100000-cancer-patients-to-find-their-clinical-trial-powered-by-artificial-intelligence-3/ 2022-10-26T12:00:57+00:00 https://medicaex.com/wp-content/uploads/2022/10/massive-bio-logo402x-Rovxeh.jpeg https://medicaex.com/businesswire/orionis-biosciences-demonstrates-platform-capabilities-of-genome-scale-molecular-glue-discovery-and-rational-design-at-targeted-protein-degradation-summit/ 2022-10-26T12:00:56+00:00 https://medicaex.com/wp-content/uploads/2022/10/Orionis_Logo_web_Black-01-rk9kAm.jpeg https://medicaex.com/businesswire/global-diagnostic-imaging-services-market-report-2022-early-disease-detection-and-rising-incidence-of-age-associated-diseases-to-drive-growth-researchandmarkets-com/ 2022-10-26T12:00:56+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-Ld81dK.jpeg https://medicaex.com/businesswire/aldeyra-therapeutics-announces-oral-presentation-of-phase-3-data-at-the-american-academy-of-optometry-2022-annual-meeting/ 2022-10-26T12:00:55+00:00 https://medicaex.com/wp-content/uploads/2022/10/ALDX_logo_JPEG-XVHEkc.jpeg https://medicaex.com/businesswire/multi-omics-startup-pleno-inc-expands-leadership-team-to-accelerate-development-of-its-novel-hypercoding-technology-2/ 2022-10-26T12:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/Pleno_Logo_High_Resolution-Aoy9xh.jpeg https://medicaex.com/businesswire/iqvia-reports-third-quarter-2022-results-2/ 2022-10-26T12:00:42+00:00 https://medicaex.com/businesswire/caredx-to-report-third-quarter-2022-financial-results/ 2022-10-26T12:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/CareDx_Logo-tPOXfG.jpeg https://medicaex.com/businesswire/fortive-reports-strong-third-quarter-2022-results-narrows-and-raises-full-year-2022-outlook/ 2022-10-26T12:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/Fortive_Logo-s1HHEV.jpeg https://medicaex.com/businesswire/massive-bio-onboards-over-100000-cancer-patients-to-find-their-clinical-trial-powered-by-artificial-intelligence-2/ 2022-10-26T12:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/10/massive-bio-logo402x-47YXsz.jpeg https://medicaex.com/businesswire/global-sterilization-equipment-market-report-2022-to-2027-stringent-environmental-regulations-worldwide-are-driving-growth-researchandmarkets-com-2/ 2022-10-26T12:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-BazJiy.jpeg https://medicaex.com/businesswire/caredx-joins-forces-with-national-kidney-foundation-and-honor-the-gift-coalition-to-host-immuno-bill-webinar-for-kidney-transplant-patients/ 2022-10-26T12:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/CareDx_Logo-LKoIq5.jpeg https://medicaex.com/businesswire/docgo-expands-service-area-of-innovative-mobile-urgent-care-in-new-york-city-and-new-jersey/ 2022-10-26T12:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/DocGo_Primary_Logo-nKYX1m.jpeg https://medicaex.com/businesswire/medable-enhances-patient-experience-in-oncology-clinical-trials-to-increase-access-enrollment-retention/ 2022-10-26T12:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo_Full_Color_2x-WkonWD.jpeg https://medicaex.com/businesswire/beigene-expands-reach-of-its-innovative-btk-inhibitor-with-recent-regulatory-approvals-in-latin-america/ 2022-10-26T11:00:55+00:00 https://medicaex.com/wp-content/uploads/2022/10/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-SfWe0p.jpeg https://medicaex.com/businesswire/expansion-therapeutics-appoints-raymond-kelleher-m-d-ph-d-to-its-board-of-directors/ 2022-10-26T11:00:54+00:00 https://medicaex.com/wp-content/uploads/2022/10/Raymond_Kelleher_Photo-DiEcit.jpeg https://medicaex.com/businesswire/iqvia-reports-third-quarter-2022-results/ 2022-10-26T11:00:54+00:00 https://medicaex.com/businesswire/precision-biosciences-announces-grant-of-inducement-award-pursuant-to-nasdaq-listing-rule-5635c4/ 2022-10-26T11:00:54+00:00 https://medicaex.com/wp-content/uploads/2022/10/Precision_BioSciences_logo-fhNv09.jpeg https://medicaex.com/businesswire/multi-omics-startup-pleno-inc-expands-leadership-team-to-accelerate-development-of-its-novel-hypercoding-technology/ 2022-10-26T11:00:53+00:00 https://medicaex.com/wp-content/uploads/2022/10/Pleno_Logo_High_Resolution-BuwxLu.jpeg https://medicaex.com/businesswire/endoluxe-joins-nvidia-inception/ 2022-10-26T11:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/10/Endoluxe_Logo_BusinessWire-01-rdZO1C.jpeg https://medicaex.com/businesswire/senseonics-holdings-inc-schedules-third-quarter-2022-earnings-release-and-conference-call-for-november-8-2022-at-430-p-m-eastern-time/ 2022-10-26T11:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/10/SENS_logo-EODL9E.jpeg https://medicaex.com/businesswire/nextgen-healthcare-reports-fiscal-2023-second-quarter-results/ 2022-10-26T11:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/10/NG_Logo_Final_RGB_300-uH3pSR.jpeg https://medicaex.com/businesswire/atlas-health-expands-leadership-team/ 2022-10-26T11:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/10/Atlas_Health_Logo-rem2XC.jpeg https://medicaex.com/businesswire/teledyne-technologies-reports-third-quarter-results/ 2022-10-26T11:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/10/Teledyne_Technologies_w_Tag_Black_Blue_COLOR-4PqSNH.jpeg https://medicaex.com/businesswire/bristol-myers-squibb-reports-third-quarter-financial-results-for-2022-2/ 2022-10-26T11:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/BMS_LOGO-1irJD4.jpeg https://medicaex.com/businesswire/masimo-to-report-third-quarter-2022-financial-results-after-market-close-on-tuesday-november-8/ 2022-10-26T11:00:42+00:00 https://medicaex.com/businesswire/varex-schedules-fourth-quarter-and-fiscal-year-2022-earnings-release-and-conference-call/ 2022-10-26T11:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/Varex_Logo_Horizontal-cri4M3.jpeg https://medicaex.com/businesswire/biocorp-and-novo-nordisk-strengthen-their-partnership-with-a-new-agreement-on-mallya-smart-sensor/ 2022-10-26T11:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/LOGO-BLEU-vUMKv8.jpeg https://medicaex.com/businesswire/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities/ 2022-10-26T11:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/3DS_Corp_Logotype_Blue_RGB-Epd5c6.jpeg https://medicaex.com/businesswire/insights-on-the-pen-needles-3-6-billion-global-market-to-2027-advancements-in-insulin-delivery-methods-drives-demand-researchandmarkets-com/ 2022-10-26T11:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-H4eYPl.jpeg https://medicaex.com/businesswire/dr-david-wong-of-ucla-to-present-on-saliva-liquid-biopsy-research-using-spectrum-solutions-saliva-collection-device-for-the-detection-of-cancer-biomarkers-at-ashg-2022/ 2022-10-26T11:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/Spectrum_Solutions_Logo_Style_Guide-06_2800229-eANUzP.jpeg https://medicaex.com/businesswire/global-cardiovascular-needle-market-to-grow-by-7-61-annually-through-2029-researchandmarkets-com/ 2022-10-26T11:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-89pD19.jpeg https://medicaex.com/businesswire/bristol-myers-squibb-reports-third-quarter-financial-results-for-2022/ 2022-10-26T11:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/BMS_LOGO-KXf9XI.jpeg https://medicaex.com/businesswire/assure-infusions-breaks-ground-on-advanced-robotics-manufacturing-plant/ 2022-10-26T11:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/AI_Groundbreaking-Xb4y1F.jpeg https://medicaex.com/businesswire/whoop-announces-scientific-advisory-council-to-advance-its-mission-to-unlock-human-performance/ 2022-10-26T11:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/whoop-logo1-dsaQoy.jpeg https://medicaex.com/businesswire/medx-announces-final-closing-of-issuance-of-series-iii-convertible-loan-notes/ 2022-10-26T11:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/MedX_Logo_copy-ZR7HRB.jpeg https://medicaex.com/businesswire/trialbee-to-highlight-patient-recruitment-advances-to-support-clinical-trials-during-three-sessions-at-festival-of-biologics/ 2022-10-26T11:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/Trialbee-Logo_28129-nBBIFS.jpeg https://medicaex.com/businesswire/at-home-health-testing-powered-by-ixlayer-hit-store-shelves-and-available-online/ 2022-10-26T11:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/ixlayer_-_CVS_Partnership_Logo-YFmeKm.jpeg https://medicaex.com/businesswire/alyka-health-launches-innovative-mobile-health-application/ 2022-10-26T11:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/Transparent_V2_with_padding-nYg4IX.jpeg https://medicaex.com/businesswire/atara-biotherapeutics-presents-new-mri-and-updated-open-label-extension-data-from-phase-1-study-of-ata188-in-progressive-multiple-sclerosis-at-ectrims-2022/ 2022-10-26T10:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/Atara-Bio1_logo_300x185-1-QX7lDd.jpeg https://medicaex.com/businesswire/merck-highlights-new-data-for-evobrutinib-first-btki-to-demonstrate-sustained-clinical-benefit-for-people-with-rms-through-three-and-a-half-years-of-treatment/ 2022-10-26T10:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Asset_5402x_2800229-A7ysOZ.jpeg https://medicaex.com/businesswire/emd-serono-highlights-new-data-for-evobrutinib-first-btki-to-demonstrate-sustained-clinical-benefit-for-people-with-rms-through-three-and-a-half-years-of-treatment/ 2022-10-26T10:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/MERCK_EMDS_RBlue_RGB-MlkoUO.jpeg https://medicaex.com/businesswire/exelixis-announces-promising-initial-dose-escalation-results-from-the-first-in-human-phase-1-jewel-101-trial-evaluating-xb002-in-patients-with-advanced-solid-tumors-at-ena-2022/ 2022-10-26T10:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/10/Exelixis_Logo_JPG-rnoHvG.jpeg https://medicaex.com/businesswire/scorpion-therapeutics-presents-preclinical-proof-of-concept-data-for-stx-721-a-next-generation-exon-20-mutant-egfr-inhibitor-at-the-eortc-nci-aacr-symposium-2022/ 2022-10-26T10:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/Scorpion_Logo-92WVsg.jpeg